Financial Metrics Unveiled: Apogee Therapeutics Inc (APGE)’s Key Ratios in the Spotlight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

The price of Apogee Therapeutics Inc (NASDAQ: APGE) closed at $41.86 in the last session, down -1.37% from day before closing price of $42.44. In other words, the price has decreased by -$1.37 from its previous closing price. On the day, 1.04 million shares were traded.

Ratios:

We take a closer look at APGE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $95.

On November 25, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $89.

On May 10, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $80.BofA Securities initiated its Buy rating on May 10, 2024, with a $80 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 04 ’25 when Dambkowski Carl sold 2,725 shares for $36.96 per share. The transaction valued at 100,716 led to the insider holds 241,723 shares of the business.

Dambkowski Carl sold 2,725 shares of APGE for $97,419 on May 07 ’25. The Chief Medical Officer now owns 244,448 shares after completing the transaction at $35.75 per share. On Apr 02 ’25, another insider, Dambkowski Carl, who serves as the Chief Medical Officer of the company, sold 3,860 shares for $36.22 each. As a result, the insider received 139,801 and left with 247,173 shares of the company.

Stock Price History:

Over the past 52 weeks, APGE has reached a high of $63.50, while it has fallen to a 52-week low of $26.20. The 50-Day Moving Average of the stock is 12.98%, while the 200-Day Moving Average is calculated to be -4.56%.

Shares Statistics:

A total of 46.04M shares are outstanding, with a floating share count of 37.32M. Insiders hold about 37.32% of the company’s shares, while institutions hold 88.24% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.